Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.65%33.29M | 17.82%34.54M | -50.82%22.36M | -7.23%144.31M | 25.62%42.2M | -40.43%27.83M | -2.63%29.32M | 0.71%45.47M | 64.81%155.56M | 661.29%33.59M |
| Cost of revenue | -29.89%24.87M | 13.10%31.45M | -46.50%24.26M | 1.58%150.62M | 25.02%41.74M | -22.80%35.47M | 9.83%27.81M | 7.84%45.35M | 72.49%148.28M | 217.10%33.38M |
| Gross profit | 210.19%8.43M | 104.63%3.1M | -1,657.38%-1.9M | -186.66%-6.31M | 119.81%466K | -1,103.41%-7.65M | -68.44%1.51M | -96.06%122K | -13.54%7.28M | 103.47%212K |
| Operating expense | -40.50%2.85M | 19.56%4.25M | 1.74%3.74M | 17.82%16.68M | 2.69%3.98M | 18.81%4.79M | 30.48%3.55M | 47.65%3.68M | 3.12%14.16M | 0.74%3.87M |
| Selling and administrative expenses | -20.16%2.63M | -2.06%3.28M | -21.93%2.91M | 2.04%13.92M | 6.35%3.02M | -12.62%3.29M | -4.62%3.35M | 17.72%3.72M | -3.16%13.64M | -33.11%2.84M |
| -General and administrative expense | -20.16%2.63M | -2.06%3.28M | -21.93%2.91M | 2.04%13.92M | 6.35%3.02M | -12.62%3.29M | -4.62%3.35M | 17.72%3.72M | -3.16%13.64M | -33.11%2.84M |
| Other operating expenses | -85.07%224K | 367.31%972K | --834K | 433.52%2.76M | -7.32%962K | 461.80%1.5M | --208K | ---- | --517.87K | --1.04M |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -93.15%46K | ---- | ---- |
| Operating profit | 144.84%5.58M | 43.53%-1.15M | -58.71%-5.64M | -234.36%-22.99M | 4.10%-3.51M | -280.48%-12.43M | -198.50%-2.04M | -681.51%-3.55M | -29.56%-6.88M | 63.24%-3.66M |
| Net non-operating interest income (expenses) | 1.59%-1.05M | -48.92%-1.11M | -12.69%-950K | 11.54%-3.68M | -26.85%-1.03M | -2.20%-1.07M | 44.46%-742K | 13.18%-843K | -57.65%-4.16M | -26.60%-812K |
| Non-operating interest expense | -1.59%1.05M | 48.92%1.11M | 12.69%950K | -11.54%3.68M | 26.85%1.03M | 2.20%1.07M | -44.46%742K | -13.18%843K | 57.65%4.16M | 26.60%812K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | -2,937.22%-2.12M | 141.85%1.04M | -758.75%-3.16M | 0 | 0 | 98.07%-69.7K | 20.64%-2.48M | ||
| Less:Write off | --0 | ---- | ---- | 2,937.22%2.12M | -141.85%-1.04M | 758.75%3.16M | --0 | --0 | -98.07%69.7K | -20.64%2.48M |
| Other non-operating income (expenses) | 626.55%821K | 2,267.57%876K | 1,967.50%1.65M | -67.83%843.44K | 6.38%1.2M | -72.51%113K | -75.33%37K | -39.85%80K | 341.89%2.62M | 240.39%1.13M |
| Income before tax | 132.31%5.35M | 49.69%-1.38M | -14.34%-4.94M | -229.32%-27.95M | 60.46%-2.3M | -383.78%-16.55M | -378.68%-2.75M | -1,818.22%-4.32M | 22.57%-8.49M | 56.51%-5.83M |
| Income tax | -97.83%1K | 0 | 0 | -162.50%-833.03K | -15.76%1.06M | 115.08%46K | -183.16%-390K | -1,311.36%-1.07M | 184.96%1.33M | 142.25%1.26M |
| Net income | 132.21%5.35M | 41.36%-1.38M | -51.85%-4.94M | -176.13%-27.11M | 52.50%-3.37M | -432.61%-16.6M | -556.40%-2.36M | -938.34%-3.25M | -4.56%-9.82M | 31.87%-7.09M |
| Net income continuous operations | 132.21%5.35M | 41.36%-1.38M | -51.85%-4.94M | -176.13%-27.11M | 52.50%-3.37M | -432.61%-16.6M | -556.40%-2.36M | -938.34%-3.25M | -4.56%-9.82M | 31.87%-7.09M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 132.21%5.35M | 41.36%-1.38M | -51.85%-4.94M | -176.13%-27.11M | 52.50%-3.37M | -432.61%-16.6M | -556.40%-2.36M | -938.34%-3.25M | -4.56%-9.82M | 31.87%-7.09M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 132.21%5.35M | 41.36%-1.38M | -51.85%-4.94M | -176.13%-27.11M | 52.50%-3.37M | -432.61%-16.6M | -556.40%-2.36M | -938.34%-3.25M | -4.56%-9.82M | 31.87%-7.09M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 132.21%0.0143 | 41.27%-0.0037 | -51.72%-0.0132 | -155.28%-0.0725 | 53.61%-0.009 | -382.61%-0.0444 | -520.00%-0.0063 | -866.67%-0.0087 | 10.69%-0.0284 | 45.20%-0.0194 |
| Diluted earnings per share | 132.21%0.0143 | 41.27%-0.0037 | -51.72%-0.0132 | -155.28%-0.0725 | 53.61%-0.009 | -382.61%-0.0444 | -520.00%-0.0063 | -866.67%-0.0087 | 10.69%-0.0284 | 45.20%-0.0194 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.